Results 11 to 20 of about 2,123 (172)
Prurigo nodularis. Prurigo nodularis is the most severe degree of chronic prurigo. Disseminated nodules (mostly on the 4 members) are associated with skin excoriations and an intense pruritus. Whatever the etiology, prurigo nodularis is autonomous disease which is related to itch sensitization (similar to pain sensitization). The burden is high.
Amy H Huang +2 more
exaly +7 more sources
Prurigo Nodularis at Ultra-High-Frequency Ultrasound [PDF]
Here, we describe the case of a 48-year-old female patient with prurigo nodularis, where B-mode and color-Doppler ultrasound of one nodule was performed; this revealed hypoechoic dermal and hyperechoic epidermal thickening with lesion hypervascularity ...
Alessandra Michelucci +11 more
doaj +2 more sources
Tofacitinib for Prurigo Nodularis: A Case Report
Changlan Peng,1 Chunxiao Li,2 Yingying Zhou,1 Qiuyue Wang,1 Ping Xie,1 Tianhao Li,2,* Pingsheng Hao2,* 1Department of Dermatology, Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China; 2Department of Dermatology,
Changlan Peng +2 more
exaly +2 more sources
Cost-effectiveness Analysis of Dupilumab for the Treatment of Adult Patients with Severe Prurigo Nodularis in Italy [PDF]
Prurigo nodularis is characterized by intensely pruritic nodules that significantly impact patients’ quality of life. This study aims to evaluate the cost-effectiveness of dupilumab compared with the best supportive care for the treatment of severe ...
Cataldo Patruno +6 more
doaj +2 more sources
Successful treatment of refractory prurigo nodularis with abrocitinib
Key Clinical Message Prurigo nodularis is frequently difficult to manage with conventional therapy. Given the pathogenesis and refractory nature, we demonstrate a case in which inhibition of JAK–STAT signaling may significantly improve prurigo nodularis.
Zhenzhen Wu
exaly +2 more sources
Safety, Pharmacokinetics, and Efficacy of 1.5% Ruxolitinib Gel (HDM3010) in Adult Patients with Prurigo Nodularis: A Phase I/II, Randomized, Double-Blind, Vehicle-Controlled Multicenter Clinical Trial [PDF]
Introduction Prurigo nodularis (PN) is a chronic inflammatory dermatosis with severe, persistent pruritus and limited effective therapies. Janus kinase (JAK) inhibition has emerged as a targeted strategy for PN.
Chao Wu +28 more
doaj +2 more sources
Successful Treatment of Pediatric Atopic Prurigo Nodularis with Dupilumab [PDF]
Yuping Zhang,* Lizhu Liang,* Chen Li Department of Dermatology, Zhongshan City People’s Hospital, Zhongshan City, Guangdong Province, 528403, People’s Republic of China*These authors contributed equally to this workCorrespondence:
Zhang Y, Liang L, Li C
doaj +2 more sources
Immunotargets and Therapy for Prurigo Nodularis
Angelina Labib, Teresa Ju, Ashley Vander Does, Gil Yosipovitch Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami Miller School of Medicine, Miami, FL, USACorrespondence: Gil Yosipovitch, Dr ...
Angelina Labib +2 more
exaly +2 more sources
While dialysis is linked with prurigo nodularis, little is known about the impact of non-dialysis chronic kidney disease on prurigo nodularis. The influence of chronic kidney disease on development of prurigo nodularis was measured using the Korean ...
Hei Sung Kim +2 more
doaj +1 more source
Prurigo nodularis is an extremely pruritic skin condition as a result of chronic and vicious cycle of itching and scratching. It is rare in children. We report a case of a 4-year-old child with a background of poorly controlled atopic dermatitis with ...
Henrietta Albela, Kin Fon Leong
doaj +1 more source

